
News|Articles|March 17, 2026
Challenging Cases®: Firsthand insight into oncology decision‑making
Author(s)IntrinsiQ Specialty Solutions
Through interactive, quantitative live and virtual double-blinded case-based sessions followed by a national key opinion leader data-focused discussion, Challenging Cases offers a window into how oncologists select treatment options, balance clinical considerations, and respond to complex patient scenarios, providing insight into the factors shaping real-world treatment decisions.
Trending on PharmExec
1
Where the True Bottlenecks Exist at FDA for Clinical Trials
2
argenx Acquires Forte Biosciences for $2.2 Billion
3
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
4
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
5